Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125236712 | 12523671 | 2 | F | 201412 | 20160707 | 20160704 | 20160713 | EXP | JP-ROCHE-1787078 | ROCHE | 64.00 | YR | F | Y | 0.00000 | 20160713 | MD | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125236712 | 12523671 | 1 | PS | LUCENTIS | RANIBIZUMAB | 1 | Other | U | 125156 | .05 | ML | SOLUTION FOR INJECTION | |||||||
125236712 | 12523671 | 2 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | U | 125156 | .05 | ML | ||||||||
125236712 | 12523671 | 3 | SS | LUCENTIS | RANIBIZUMAB | 1 | Other | U | 125156 | .05 | ML |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125236712 | 12523671 | 1 | Retinal vein occlusion |
125236712 | 12523671 | 2 | Macular oedema |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125236712 | 12523671 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125236712 | 12523671 | Macular oedema | |
125236712 | 12523671 | Retinal ischaemia | |
125236712 | 12523671 | Retinal oedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125236712 | 12523671 | 1 | 201409 | 0 | ||
125236712 | 12523671 | 2 | 201412 | 0 | ||
125236712 | 12523671 | 3 | 201508 | 0 |